$ATXI Income Statement | Understand Stock

$ATXI

$0.54 -$0.03 (4.48%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Other revenue
Operating expenses
Research and development
Research and development - licenses acquired
General and administrative
Gain on sale of Baergic
Total operating expenses
Loss from operations
Interest income
Financing costs - warrant liabilities
Financing costs – warrant liabilities
Loss on common stock warrant liabilities
Change in fair value of warrant liability
Net loss
Net loss attributable to non-controlling interest
Net loss attributable to common stockholders
Net loss per common share attributable to common stockholders, basic
Net loss per common share attributable to common stockholders, basic and diluted (in dollars per share)
Net loss per common share outstanding, diluted
Weighted average number of common shares outstanding, basic and diluted (in shares)

Comments